GB 00160-75

C52GBZGBZ/T160.752004Methodsfordeterminationofheterocycliccompoundsintheairofworkplace20045212004121GBZ/T160.752004GBZ1GBZ2[PyridineFuranTetrahydrofuran]2004121GB/T16116-1995GB16235-1996AGB16231-1996AB1995GBZ/T160.752004123-3.14013.23.2.1401150mg/75mg4013.2.2100mg/50mg3.2.30~500ml/min3.2.45ml3.2.510μl3.2.62m4mmFFAP:ChromosorbWAWDMCS=10:100100oC160oC160oC45ml/min3.33.3.140120401202h3.3.220406mol/L30min50g/L10min1403.3.33.3.4FFAP3.3.5ChromosorbWAWDMCS60803.3.610ml5ml1.0mg/ml3.4GBZ1593.4.1100ml/min15min3.4.250ml/min2~8h3.4.350ml/min2~8h7d7d3.53.5.13.5.21.0ml1min30min3.5.30.010.025.050.0100250μg/ml0102040g/ml2.0μl3(μg/ml)3.5.4(μg/ml)3.63.6.11293PVo=V1273+t101.3VoLVLtPkPa3.6.22(c1+c2)vC=2VoDCmg/m3c1,c2μg/mlvmlVoLD3.6.3GBZ1593.73.7.15.1μg/ml0.5μg/ml3.4mg/m30.3mg/m31.5L5.1~250μg/ml0.540μg/ml2.55.93.7.2100mg2.64mg21mg10082.53.7.33.7.44-4.14.24.2.1100mg4.2.20~500ml/min4.2.34.2.4100ml1ml4.2.52m4mmFFAP:ChromosorbWAWDMCS=10:1005515015030ml/min4.34.3.1FFAP4.3.2ChromosorbWAWDMCS60804.3.3201μl0.9514mg0.8892mg100ml100ml4.4GBZ1594.4.1100ml/min15min4.4.250ml/min2~8h4.4.350ml/min2~8h7d4.54.5.14.5.2100ml50ml/min250100ml4.5.30.02.510-45.010-425.010-4μg/ml0.00.150.601.50μg/ml1.0ml3(μg/ml)4.5.4(μg/ml)4.64.6.114.6.23cC=1003VoDCmg/m3cμg/ml100mlDVoL4.6.3GBZ1594.74.7.11.010-4μg/ml2.310-3μg/ml0.0067mg/m30.15mg/m31.5L1.010-42510-4μg/ml2.310-31.5μg/ml1.2%1.6%0.9%1.5%4.7.2100mg2.64mg9.36mg99.8%1004.7.399.5%97.4%4.7.44.7.5